Entereg

U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Yahoo/Reuters
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Flag link:
2013 FDA Drug Approval Calendar
2013 FDA Drug Approval Calendar
TheStreet.com
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Flag link:
Cubist Submits ENTEREG Supplemental NDA
Cubist Submits ENTEREG Supplemental NDA
Pipeline Review
Cubist Pharmaceuticals
Entereg
GI recovery
Flag link:
Cubist Submits ENTEREG Supplemental NDA
Cubist Submits ENTEREG Supplemental NDA
Yahoo
Entereg
Cubist Pharmaceuticals
bowel resection
Flag link:
Cubist Pharmaceuticals: Promising Biotech For The Future
Cubist Pharmaceuticals: Promising Biotech For The Future
Seeking Alpha
Cubist Pharmaceuticals
Teva
Entereg
Cubicin
Flag link:
Adolor buys back Entereg rights from GlaxoSmithKline
Adolor buys back Entereg rights from GlaxoSmithKline
Bizjournals.com
GSK
Adolor
Entereg
Flag link:
Adolor to buy out GSK stake in Entereg
Adolor to buy out GSK stake in Entereg
Bizjournals.com
GSK
Entereg
Adolor
Flag link:
Adolor to cut 30 jobs as Entereg sales disappoint
Adolor to cut 30 jobs as Entereg sales disappoint
Yahoo/AP
Adolor
layoffs
Entereg
Flag link:
Adolor narrows 4Q loss as Entereg sales increase
Adolor narrows 4Q loss as Entereg sales increase
Yahoo/AP
Adolor
earnings
Entereg
Flag link:
Possible new use for Adolor drug abandoned
Possible new use for Adolor drug abandoned
Bizjournals.com
Adolor
Entereg
GSK
Flag link: